Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001628280-25-057141
Filing Date
2025-12-15
Accepted
2025-12-15 17:34:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2846
2 EX-99.TABLE II table_ii.pdf EX-99.TABLE II 178711
  Complete submission text file 0001628280-25-057141.txt   251014
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Fund X, L.P. (Reporting) CIK: 0001628098 (see all company filings)

EIN.: 472435989 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Subject) CIK: 0001816736 (see all company filings)

EIN.: 851612845 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39438 | Film No.: 251572669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)